RESEARCH
Circulating tumor DNA detects recurrence months before imagingA review of 94 publications found that postoperative ctDNA positivity was consistently associated with increased recurrence risk and poorer survival, with serial monitoring identifying molecular recurrence approximately 2.5 to 11.5 months before conventional surveillance. (Current Oncology)